Monoclinic α-Na2FePO4F with strong antisite disorder and enhanced Na+ diffusion
dc.contributor.author | Kirsanova, MA | en_AU |
dc.contributor.author | Akmaev, AS | en_AU |
dc.contributor.author | Aksyonov, DA | en_AU |
dc.contributor.author | Ryazantsev, SV | en_AU |
dc.contributor.author | Nikitina, VA | en_AU |
dc.contributor.author | Filimonov, DS | en_AU |
dc.contributor.author | Avdeev, M | en_AU |
dc.contributor.author | Abakumov, AM | en_AU |
dc.date.accessioned | 2021-07-09T04:40:14Z | en_AU |
dc.date.available | 2021-07-09T04:40:14Z | en_AU |
dc.date.issued | 2020-11-02 | en_AU |
dc.date.statistics | 2021-07-05 | en_AU |
dc.description.abstract | A new monoclinic α-polymorph of the Na2FePO4F fluoride-phosphate has been directly synthesized via a hydrothermal method for application in metal-ion batteries. The crystal structure of the as-prepared α-Na2FePO4F studied with powder X-ray and neutron diffraction (P21/c, a = 13.6753(10) Å, b = 5.2503(2) Å, c = 13.7202(8) Å, β = 120.230(4)°) demonstrates strong antisite disorder between the Na and Fe atoms. As revealed with DFT-based calculations, α-Na2FePO4F has low migration barriers for Na+ along the main pathway parallel to the b axis, and an additional diffusion bypass allowing the Na+ cations to go around the Na/Fe antisite defects. These results corroborate with the extremely high experimental Na-ion diffusion coefficient of (1–5)·10–11 cm2·s–1, which is 2 orders of magnitude higher than that for the orthorhombic β-polymorph ((5–10)·10–13 cm2·s–1). Being tested as a cathode material in Na- and Li-ion battery cells, monoclinic α-Na2FePO4F exhibits a reversible specific capacity of 90 and 80 mAh g–1, respectively. © 2020 American Chemical Society | en_AU |
dc.identifier.citation | Kirsanova, M. A., Akmaev, A. S., Aksyonov, D. A., Ryazantsev, S. V., Nikitina, V. A., Filimonov, D. S., Avdeev, M., & Abakumov, A. M. (2020). Monoclinic α-Na2FePO4F with strong antisite disorder and enhanced Na+ diffusion. Inorganic Chemistry, 59(22), 16225-16237. doi:10.1021/acs.inorgchem.0c01961 | en_AU |
dc.identifier.issn | 1520-510X | en_AU |
dc.identifier.issue | 22 | en_AU |
dc.identifier.journaltitle | Inorganic Chemistry | en_AU |
dc.identifier.pagination | 16225-16237 | en_AU |
dc.identifier.uri | https://doi.org/10.1021/acs.inorgchem.0c01961 | en_AU |
dc.identifier.uri | https://apo.ansto.gov.au/dspace/handle/10238/11045 | en_AU |
dc.identifier.volume | 59 | en_AU |
dc.language.iso | en | en_AU |
dc.publisher | American Chemical Society | en_AU |
dc.subject | Crystal structure | en_AU |
dc.subject | Sodium | en_AU |
dc.subject | Electrochemical cells | en_AU |
dc.subject | Monoclinic lattices | en_AU |
dc.subject | Neutron diffraction | en_AU |
dc.subject | X-ray diffraction | en_AU |
dc.title | Monoclinic α-Na2FePO4F with strong antisite disorder and enhanced Na+ diffusion | en_AU |
dc.type | Journal Article | en_AU |
Files
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 1.63 KB
- Format:
- Item-specific license agreed upon to submission
- Description: